Loss of function studies in gastric (55), hepatocellular carcinoma (56), prostate cancer (34) and pancreatic cancer cells (57) indicated tumorigenic and growth-promoting activities of MAP4K4. The gene discussed is MAP4K4; the disease is familial pancreatic carcinoma.